These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1997392)

  • 41. Apolipoprotein EBethesda: a new variant of apolipoprotein E associated with type III hyperlipoproteinemia.
    Gregg RE; Ghiselli G; Brewer HB
    J Clin Endocrinol Metab; 1983 Nov; 57(5):969-74. PubMed ID: 6578216
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hereditary spherocytosis and hemochromatosis.
    Brandenberg JB; Demarmels Biasiutti F; Lutz HU; Wuillemin WA
    Ann Hematol; 2002 Apr; 81(4):202-9. PubMed ID: 11976822
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Type III hyperlipoproteinemia and atherosclerosis: a case report and re-evaluation.
    Gown AM; Hazzard WR; Benditt EP
    Hum Pathol; 1982 May; 13(5):506-10. PubMed ID: 7076231
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Abnormal regulation of HFE mRNA expression does not contribute to primary iron overload.
    Vercesi E; Cerani P; Rolandi V; Rovati A; Bergamaschi G
    Haematologica; 2000 Aug; 85(8):787-91. PubMed ID: 10942923
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inheritance of hemochromatosis: linkage to HLA.
    Cartwright GE; Skolnick M; Amos DB; Edwards CQ; Kravitz K; Johnson A
    Trans Assoc Am Physicians; 1978; 91():273-81. PubMed ID: 754395
    [No Abstract]   [Full Text] [Related]  

  • 46. Serum ferritin as a possible marker of the hemochromatosis allele.
    Beaumont C; Simon M; Fauchet R; Hespel JP; Brissot P; Genetet B; Bourel M
    N Engl J Med; 1979 Jul; 301(4):169-74. PubMed ID: 449973
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myelomatosis with type III hyperlipoproteinemia: clinical and metabolic studies.
    Cortese C; Lewis B; Miller NE; Peyman MA; Rao SN; Slavin B; Sule U; Turner PR; Utermann G; Wing AJ; Weight M; Wootton R
    N Engl J Med; 1982 Jul; 307(2):79-83. PubMed ID: 6283345
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Combined familial hypercholesterolemia and type III hyperlipoproteinemia].
    Levy Y; Aviram M; Baruch Y; Brook JG
    Harefuah; 1984 Jun; 106(12):565-6. PubMed ID: 6479724
    [No Abstract]   [Full Text] [Related]  

  • 49. [Hereditary hemochromatosis associated with hypoceruloplasminemia with absence of mutations in the HFE gene]].
    Del Rey R; Froilán C; Comas C; Villanueva R; Olveira A
    Rev Esp Enferm Dig; 2000 Sep; 92(9):610-1. PubMed ID: 11138244
    [No Abstract]   [Full Text] [Related]  

  • 50. Heterozygosity for the H63D mutation in the hereditary hemochromatosis (HFE) gene may lead into severe iron overload in beta-thalassemia minor: observations in a thalassemic kindred.
    Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Sánchez-Anzaldo J; Ruiz-Delgado GJ; Jiménez-González C; Carrera B
    Rev Invest Clin; 2001; 53(2):117-20. PubMed ID: 11421105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Specific diagnosis of familial dysbetalipoproteinemia in Denmark. Report of a family study].
    Gerdes LU; Faergeman O
    Ugeskr Laeger; 1988 Jan; 150(4):230-2. PubMed ID: 3376331
    [No Abstract]   [Full Text] [Related]  

  • 52. Hereditary haemochromatosis.
    Edwards CQ; Dadone MM; Skolnick MH; Kushner JP
    Clin Haematol; 1982 Jun; 11(2):411-35. PubMed ID: 7042159
    [No Abstract]   [Full Text] [Related]  

  • 53. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis.
    Aguilar-Martinez P; Esculié-Coste C; Bismuth M; Giansily-Blaizot M; Larrey D; Schved JF
    Blood Cells Mol Dis; 2001; 27(1):290-3. PubMed ID: 11358390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of plasmapheresis on familial type III hyperlipoproteinemia associated with glomerular lipidosis, nephrotic syndrome and diabetes mellitus.
    Suzaki K; Kobori S; Ueno S; Uehara M; Kayashima T; Takeda H; Fukuda S; Takahashi K; Nakamura N; Uzawa H
    Atherosclerosis; 1990 Jan; 80(3):181-9. PubMed ID: 2310424
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Essential hypertension genetics, HLA associations, and heterozygous hemochromatosis.
    Sullivan JL
    Am J Med; 1993 Nov; 95(5):552. PubMed ID: 8238077
    [No Abstract]   [Full Text] [Related]  

  • 56. Nephrotic syndrome associated with severe hypertriglyceridemia in a pediatric patient: Answers.
    Corredor-Andrés B; Muñoz-Calvo MT; Calero O; Aparicio C; Argente J; Calero M
    Pediatr Nephrol; 2018 Nov; 33(11):2075-2078. PubMed ID: 29532233
    [No Abstract]   [Full Text] [Related]  

  • 57. Severe hypertriglyceridemia and recurrent pancreatitis in a girl with type Ia glycogen storage disease and type III hyperlipoproteinemia.
    Vivatrat N; Barshop BA; Jones KL
    Am J Med Genet A; 2009 Nov; 149A(11):2557-9. PubMed ID: 19842193
    [No Abstract]   [Full Text] [Related]  

  • 58. [Hemochromatosis].
    Tamura S; Kawata S; Kono N; Tarui S
    Nihon Rinsho; 1991 Feb; 49 Suppl():623-8. PubMed ID: 2033859
    [No Abstract]   [Full Text] [Related]  

  • 59. Type III hyperlipoproteinaemia and primary amenorrhoea associated with severe hypothyroidism.
    Krsek M; Ceska R; Horínek A; Horejsí B; Weiss V
    Acta Paediatr; 2000 Aug; 89(8):1023-4. PubMed ID: 10976851
    [No Abstract]   [Full Text] [Related]  

  • 60. Juvenile genetic hemochromatosis is clinically and genetically distinct from the classical HLA-related disorder.
    Cazzola M; Cerani P; Rovati A; Iannone A; Claudiani G; Bergamaschi G
    Blood; 1998 Oct; 92(8):2979-81. PubMed ID: 9763590
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.